Sepraspray

DEVICE4 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

Abdominal AdhesionsAdhesion PreventionAdhesion Prevention (Abdominal)Laparoscopic Myomectomy

Unknown Phase

Sepraspray™ Laparoscopic Myomectomy Study

CompletedNCT00624390

Genzyme, a Sanofi CompanyLaparoscopic Myomectomy

Start: 2007-11-30End: 2008-12-31Updated: 2016-12-14

Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions

TerminatedNCT00665730

Genzyme, a Sanofi CompanyAbdominal Adhesions

Start: 2007-07-31End: 2008-06-30Updated: 2015-05-08

Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

TerminatedNCT00778479

Genzyme, a Sanofi CompanyAdhesion Prevention (Abdominal)

Start: 2008-10-31End: 2009-05-31Updated: 2015-03-24

Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

CompletedNCT00813397

Genzyme, a Sanofi CompanyAdhesion Prevention

Start: 2008-09-30End: 2009-07-31Updated: 2015-05-22

Related Papers

A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery.

2014-10-279 citations